These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4097281)

  • 1. Metabolic error of muscle metabolism after recovery from malignant hyperthermia.
    Kalow W; Britt BA; Terreau ME; Haist C
    Lancet; 1970 Oct; 2(7679):895-8. PubMed ID: 4097281
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current data on the screening of malignant hyperthermia during anesthesia].
    Krivosic-Horber R; Adnet P
    Chirurgie; 1993-1994; 119(1-2):55-8. PubMed ID: 7995103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Na(+)-Ca2+ exchange influences halothane and caffeine contractures of malignant hyperthermic skeletal muscle.
    Williams JH; Lee JC; Holland M
    Res Commun Chem Pathol Pharmacol; 1992 Aug; 77(2):253-6. PubMed ID: 1439194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro contracture testing for determination of susceptibility to malignant hyperthermia: a methodologic update.
    Iaizzo PA; Wedel DJ; Gallagher WJ
    Mayo Clin Proc; 1991 Oct; 66(10):998-1004. PubMed ID: 1833602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro contracture tests for susceptibility to malignant hyperthermia.
    Rosenberg H; Reed S
    Anesth Analg; 1983 Apr; 62(4):415-20. PubMed ID: 6829945
    [No Abstract]   [Full Text] [Related]  

  • 6. Are myotonias and periodic paralyses associated with susceptibility to malignant hyperthermia?
    Lehmann-Horn F; Iaizzo PA
    Br J Anaesth; 1990 Nov; 65(5):692-7. PubMed ID: 2248848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical basis of malignant hyperpyrexia.
    Moulds RF; Denborough MA
    Br Med J; 1974 May; 2(5913):241-4. PubMed ID: 4827070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State of contracture in malignant hyperthermia.
    Hoech GP; Jones GO
    Anesthesiology; 1971 Aug; 35(2):231-3. PubMed ID: 5568145
    [No Abstract]   [Full Text] [Related]  

  • 9. Prediction of malignant hyperthermia susceptibility by clinical signs.
    Larach MG; Rosenberg H; Larach DR; Broennle AM
    Anesthesiology; 1987 Apr; 66(4):547-50. PubMed ID: 3565822
    [No Abstract]   [Full Text] [Related]  

  • 10. Malignant hyperthermia--an investigation of three patients.
    Britt BA
    Ann R Coll Surg Engl; 1971 Feb; 48(2):73-5. PubMed ID: 4251636
    [No Abstract]   [Full Text] [Related]  

  • 11. Porcine malignant hyperthermia: effects of temperature and extracellular calcium concentration on halothane-induced contracture of susceptible skeletal muscle.
    Nelson TE; Bedell DM; Jones EW
    Anesthesiology; 1975 Mar; 42(3):301-6. PubMed ID: 1115384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of procaine in the treatment of malignant hyperpyrexia.
    Clarke IM; Ellis FR
    Br J Anaesth; 1975 Jan; 47(1):17-21. PubMed ID: 1148070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of calcium ions for in vitro malignant hyperthermia testing.
    Fletcher JE; Huggins FJ; Rosenberg H
    Can J Anaesth; 1990 Sep; 37(6):695-8. PubMed ID: 2208545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porcine malignant hyperthermia: effect of dantrolene sodium on in-vitro halothane-induced contraction of susceptible muscle.
    Anderson IL; Jones EW
    Anesthesiology; 1976 Jan; 44(1):57-61. PubMed ID: 1244776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant hyperthermia: normal muscle calcium uptake and abnormal caffeine and halothane contractures.
    Jaffe RS; Martucci RW; Gronert GA; Elliott TE; Cardinet GH
    Anesthesiology; 1991 Sep; 75(3):525-6. PubMed ID: 1888058
    [No Abstract]   [Full Text] [Related]  

  • 16. An in-vitro model of anesthetic hypertonic hyperpyrexia, halothane--caffeine-induced muscle contractures: prevention of contracture by procainamide.
    Strobel GE; Bianchi CP
    Anesthesiology; 1971 Nov; 35(5):465-73. PubMed ID: 5315431
    [No Abstract]   [Full Text] [Related]  

  • 17. The temperature dependence of halothane-induced contractures of skeletal muscle.
    Suarez-Kurtz G; Sudo RT
    Muscle Nerve; 1986 Jan; 9(1):47-50. PubMed ID: 3951480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Halothane-caffeine contracture testing in neuromuscular diseases.
    Heiman-Patterson TD; Rosenberg H; Fletcher JE; Tahmoush AJ
    Muscle Nerve; 1988 May; 11(5):453-7. PubMed ID: 3374516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Halothane-induced muscle contracture as a cause of hyperpyrexia.
    Ellis FR; Harriman DG; Keaney NP; Kyei-Mensah K; Tyrrell JH
    Br J Anaesth; 1971 Jul; 43(7):721-2. PubMed ID: 5564247
    [No Abstract]   [Full Text] [Related]  

  • 20. Malignant hyperpyrexia.
    Br Med J; 1968 Jul; 3(5610):69-70. PubMed ID: 5662959
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.